ViaDerma(VDRM)
$0.000.00 (0.00%)
VDRM
ViaDerma financials statements
$0.00
At close:0.00 (0.00%)
Want to see VDRM full AI Analyst Report?
ViaDerma (VDRM) Ratios
70 Followers
ViaDerma Ratios
VDRM's free cash flow for Q3 2024 was $-874.84K. For the 2024 fiscal year, VDRM's free cash flow was increased by $0.00 and operating cash flow was $-874.84K. See a summary of the company’s cash flow.
| Ratios | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.10 | 0.28 | 0.10 | 0.05 | 0.02 |
| Quick Ratio | 1.10 | 0.28 | 0.10 | 0.02 | 0.01 |
| Cash Ratio | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Solvency Ratio | 0.00 | 0.23 | -0.37 | -0.19 | -0.20 |
| Operating Cash Flow Ratio | 0.00 | -0.00 | 0.00 | -0.00 | -0.00 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -0.00 | 0.00 | -0.01 | -0.02 |
| Net Current Asset Value | $ 121.18K | $ -1.85M | $ -2.44M | $ -2.19M | $ -3.00M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.25 | 0.58 | 1.51 | 4.78 | 11.12 |
| Debt-to-Equity Ratio | 2.62 | -0.23 | -0.17 | -0.27 | -0.26 |
| Debt-to-Capital Ratio | 0.72 | -0.29 | -0.21 | -0.37 | -0.35 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 10.40 | -0.39 | -0.11 | -0.06 | -0.02 |
| Debt Service Coverage Ratio | 0.20 | 1.34 | -1.68 | -0.38 | -0.33 |
| Interest Coverage Ratio | 2.42 | 2.48 | 2.95 | -0.47 | -1.29 |
| Debt to Market Cap | 0.03 | 0.07 | 0.05 | 0.39 | 0.73 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 3.87 | 0.59 | -0.46 | -2.05 | -2.25 |
| Profitability Margins | |||||
| Gross Profit Margin | 99.97% | 99.96% | 99.48% | 94.45% | 94.83% |
| EBIT Margin | 13.41% | 127.56% | -171.81% | -2466.00% | -3254.18% |
| EBITDA Margin | 13.44% | 127.59% | -171.77% | -2464.28% | -3252.28% |
| Operating Profit Margin | 30.85% | 45.35% | 63.84% | -616.24% | -3249.25% |
| Pretax Profit Margin | 0.68% | 109.25% | -193.42% | -3764.15% | -5764.98% |
| Net Profit Margin | 0.68% | 109.25% | -193.42% | -3764.15% | -5764.98% |
| Continuous Operations Profit Margin | 0.68% | 109.25% | -193.42% | -3764.15% | -5764.98% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 2.21% | 240.90% | -302.99% | 610.83% | 177.42% |
| Return on Assets (ROA) | 0.32% | 82.73% | -361.49% | -350.86% | -865.68% |
| Return on Equity (ROE) | 3.33% | -32.02% | 40.83% | 19.73% | 20.00% |
| Return on Capital Employed (ROCE) | 150.44% | -13.29% | -13.47% | 3.23% | 11.27% |
| Return on Invested Capital (ROIC) | 41.53% | -17.15% | -16.24% | 4.42% | 15.17% |
| Return on Tangible Assets | 0.32% | 82.98% | -364.62% | -358.31% | -901.54% |
| Earnings Yield | 0.03% | 9.69% | -11.43% | -28.51% | -56.72% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.47 | 0.77 | 1.97 | 0.42 | 0.67 |
| Payables Turnover | 0.01 | 0.02 | 0.08 | 0.02 | 0.01 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.47 | 0.76 | 1.87 | 0.09 | 0.15 |
| Working Capital Turnover Ratio | -0.70 | -0.25 | -0.22 | -0.00 | -0.00 |
| Cash Conversion Cycle | -32004.40 | -21315.07 | -4426.27 | 28767.33 | -8164.42 |
| Days of Sales Outstanding | 771.11 | 473.76 | 185.41 | 862.31 | 548.68 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 47700.97 | 27828.36 |
| Days of Payables Outstanding | 32775.51 | 21788.83 | 4611.68 | 19795.95 | 36541.46 |
| Operating Cycle | 771.11 | 473.76 | 185.41 | 48563.28 | 28377.04 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.00 | -0.00 | 0.00 | -0.00 | -0.00 |
| Free Cash Flow Per Share | 0.00 | -0.00 | 0.00 | -0.00 | -0.00 |
| Dividend Paid and CapEx Coverage Ratio | 35.00 | 0.00 | 356.25 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | 35.00 | 0.00 | 356.25 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | 0.00 | -0.00 | 0.00 | -0.01 | -0.02 |
| Operating Cash Flow to Sales Ratio | 0.00 | -0.00 | 0.00 | -0.76 | -1.45 |
| Free Cash Flow Yield | 0.00% | -0.02% | 0.02% | -0.58% | -1.43% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 3046.69 | 10.32 | -8.75 | -3.51 | -1.76 |
| Price-to-Sales (P/S) Ratio | 20.79 | 11.27 | 16.93 | 132.02 | 101.65 |
| Price-to-Book (P/B) Ratio | 101.36 | -3.30 | -3.57 | -0.69 | -0.35 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 71327.28 | -4083.87 | 6105.79 | -172.66 | -69.90 |
| Price-to-Operating Cash Flow Ratio | 71327.28 | -4083.87 | 6105.79 | -172.66 | -69.90 |
| Price-to-Earnings Growth (PEG) Ratio | -30.47 | -0.06 | -0.13 | 0.14 | 0.02 |
| Enterprise Value Multiple | 158.53 | 9.42 | -10.31 | -7.40 | -5.37 |
| Enterprise Value | 12.79M | 6.50M | 9.10M | 2.09M | 1.82M |
| EV to EBITDA | 158.53 | 9.42 | -10.31 | -7.40 | -5.37 |
| EV to Sales | 21.31 | 12.02 | 17.71 | 182.47 | 174.73 |
| EV to Free Cash Flow | 73114.11 | -4355.39 | 6389.03 | -238.63 | -120.16 |
| EV to Operating Cash Flow | 73114.11 | -4355.39 | 6389.03 | -238.63 | -120.16 |
| Tangible Book Value Per Share | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Shareholders’ Equity Per Share | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | 0.00 | 0.00 | -0.00 | -0.00 | -0.00 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 0.05 | 0.86 | 1.13 | 1.53 | 1.77 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.04 | 0.02 | -0.01 | 0.02 | 0.03 |
Currency in USD
